FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3604411000001102: Lactic acid 16.7% / Salicylic acid 16.7% paint (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
15067701000001116 Lactic acid 16.7% / Salicylic acid 16.7% paint (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60497201000001119 Salicylic acid 16.7% / Lactic acid 16.7% paint en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lactic acid 16.7% / Salicylic acid 16.7% paint Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route paint.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has active ingredient Lactic acid false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has manufactured dose form Paint false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Is a Salicylic acid + Lactic acid true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Is a Lactic acid + Salicylic acid false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has active ingredient Lactic acid false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Plays role Antifungal therapeutic role true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Is a Product containing lactic acid and salicylic acid false Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has specific active ingredient Lactic acid true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has dispensed dose form Paint true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint Has manufactured dose form Paint false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salactol paint (Dermal Laboratories Ltd) Is a True Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Duofilm paint (Stiefel Laboratories Ltd) Is a False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint 15 ml Is pack of False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint 10 ml Is pack of False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint 10 ml Has VMP True Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Lactic acid 16.7% / Salicylic acid 16.7% paint 15 ml Has VMP True Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Salicylic acid 16.7% / Lactic acid 16.7% paint (J M McGill Ltd) Is a False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Salicylic acid 16.7% / Lactic acid 16.7% paint (Colorama Pharmaceuticals Ltd) Is a False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Salicylic acid 16.7% / Lactic acid 16.7% paint (AM Distributions (Yorkshire) Ltd) Is a False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier
Salicylic acid 16.7% / Lactic acid 16.7% paint (Niche Pharma Ltd) Is a False Lactic acid 16.7% / Salicylic acid 16.7% paint Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start